- Home
- PTEN vs ZLAB Comparison
PTEN vs ZLAB Comparison
Compare PTEN & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTEN
- ZLAB
- Stock Information
- Founded
- PTEN 1978
- ZLAB 2013
- Country
- PTEN United States
- ZLAB China
- Employees
- PTEN N/A
- ZLAB N/A
- Industry
- PTEN Oil & Gas Production
- ZLAB Biotechnology: Pharmaceutical Preparations
- Sector
- PTEN Energy
- ZLAB Health Care
- Exchange
- PTEN Nasdaq
- ZLAB Nasdaq
- Market Cap
- PTEN 3.4B
- ZLAB 3.4B
- IPO Year
- PTEN 1993
- ZLAB 2017
- Fundamental
- Price
- PTEN $8.34
- ZLAB $33.78
- Analyst Decision
- PTEN Buy
- ZLAB Strong Buy
- Analyst Count
- PTEN 13
- ZLAB 3
- Target Price
- PTEN $11.96
- ZLAB $55.00
- AVG Volume (30 Days)
- PTEN 10.0M
- ZLAB 779.4K
- Earning Date
- PTEN 02-05-2025
- ZLAB 02-27-2025
- Dividend Yield
- PTEN 3.84%
- ZLAB N/A
- EPS Growth
- PTEN N/A
- ZLAB N/A
- EPS
- PTEN N/A
- ZLAB N/A
- Revenue
- PTEN $5,377,911,000.00
- ZLAB $355,748,000.00
- Revenue This Year
- PTEN N/A
- ZLAB $49.04
- Revenue Next Year
- PTEN $3.36
- ZLAB $46.80
- P/E Ratio
- PTEN N/A
- ZLAB N/A
- Revenue Growth
- PTEN 29.70
- ZLAB 35.01
- 52 Week Low
- PTEN $7.15
- ZLAB $13.48
- 52 Week High
- PTEN $12.65
- ZLAB $36.60
- Technical
- Relative Strength Index (RSI)
- PTEN 44.64
- ZLAB 79.95
- Support Level
- PTEN $7.73
- ZLAB $30.61
- Resistance Level
- PTEN $9.25
- ZLAB $33.00
- Average True Range (ATR)
- PTEN 0.41
- ZLAB 1.32
- MACD
- PTEN -0.02
- ZLAB 0.58
- Stochastic Oscillator
- PTEN 38.85
- ZLAB 86.34
About PTEN Patterson-UTI Energy Inc.
Patterson-UTI Energy Inc is one of the substantial land rig drilling contractors in the United States. Its 2023 merger with NexTier greatly expanded its pressure pumping operations, as well, and the firm now controls nearly 20% of the North American market for drilling and completions services. The company operates under three reportable business segments: (i) drilling services, (ii) completion services, and (iii) drilling products. It also provides directional drilling services and tool rental services in united states onshore oil and gas basins.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-2306 for treatments across multiple solid tumor types including ovarian and certain types of breast and lung cancers; ZL-2401 which is an antibiotic in a new class of tetracycline derivatives; and ZL-2301 is an oral, small molecule which targets HCC.